This result indicates that circ‐GLG1 and KRAS may synergistically promote the invasion and metastasis of CRC and are expected to become biomarkers involved in the diagnosis and treatment of CRC119 (Figure 3; Table 1). The gene discussed is GLG1; the disease is colorectal carcinoma.